SP could go either way as these early stage biotechs are so volatile with traders taking fast profits but if SP holds above 40 cents then that would be a good base before next leg up. If the expected Ph1 intravenous trial result is announced soon then IMO previous 52 week high of 52 cents could be tested soon also.
- Forums
- ASX - By Stock
- VLA
- in the green
in the green, page-40
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin